NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-181-2006-0-AU-04 Micro-RNA Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Lung Cancer AU National Stage 2007205234 Abandoned
NCI E-181-2006-0-CN-06 Unique MicroRNA Molecular Profiles In Lung Cancer Diagnosis And Prognosis CN National Stage 200780006750.8 Abandoned
NCI E-181-2006-0-PCT-02 Unique MicroRNA Molecular Profiles In Lung Cancer Diagnosis And Prognosis PCT PCT PCT/US07/000103 Expired
NCI E-181-2006-0-CN-15 Unique MicroRNA Molecular Profiles In Lung Cancer Diagnosis And Prognosis CN DIV 201210312507.1 Abandoned
NCI E-181-2006-0-CA-05 Unique MicroRNA Molecular Profiles In Lung Cancer Diagnosis And Prognosis CA National Stage 2633674 Abandoned
NCI E-206-1995-3-JP-12 FUNCTIONAL ROLE OF ADRENOMEDULLIN (AM) AND THE GENE-RELATED PRODUCT (PAMP) IN HUMAN PATHOLOGY AND PHYSIOLOGY JP DIV 2006-349430 Abandoned
NIAID E-323-2005-2-NL-17 INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS NL EP 05751982.9 Abandoned
NIAID E-323-2005-2-BE-18 INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS BE EP 05751982.9 Abandoned
NIAID E-323-2005-2-HU-19 INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS HU EP 05751982.9 Abandoned
NIAID E-323-2005-2-ES-14 INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS ES EP 05751982.9 Abandoned
NIAID E-323-2005-2-GB-13 INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS GB EP 05751982.9 Abandoned
NIAID E-323-2005-2-CH-16 INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS CH EP 05751982.9 Abandoned
NIAID E-323-2005-2-DE-10 INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS DE EP 05751982.9 Abandoned
NIAID E-323-2005-2-FR-15 INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS FR EP 05751982.9 Abandoned
NIDCD E-168-2001-0-US-08 Transduction-1 And Transductin-2 And Applications to Hereditary Deafness US DIV 11/615,250 7659115 Expired PDF
NIAID E-243-2006-2-PCT-01 Nitroimidadzole Analogs With Improved TB Activity PCT PCT COMB PCT/US2006/048763 Expired
NIAID E-145-2004-4-PCT-01 Monoclonal Antibodies Against Orthopoxviruses PCT PCT COMB PCT/US2006/048833 Expired
NIAID E-145-2004-3-PCT-01 Monoclonal Antibodies Against Orthopoxviruses PCT PCT COMB PCT/US2006/048832 Expired
NIAID E-243-2006-2-EP-04 NITROIMIDAZOLE COMPOUNDS EP National Stage 06847903.9 Abandoned
NIAID E-243-2006-2-CA-03 Nitroimidadzole Analogs With Improved TB Activity CA National Stage 2631661 Abandoned
NIAID E-225-2000-0-AU-16 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promotor-Proximal Genes AU DIV 2006252238 Abandoned
NIAID E-243-2006-2-AU-02 Nitroimidadzole Analogs With Improved TB Activity AU National Stage 2006331676 Abandoned
NIDCR E-105-2003-0-US-03 Avian Adeno-Associated Virus (AAAV) and Uses Thereof US National Stage 10/557,662 8927269 Issued PDF
NIA E-146-1993-0-US-50 METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT US CON 11/644,411 Abandoned
NHLBI E-332-2005-0-US-01 Probe Set Optimization US 60/871,447 Abandoned
NIDDK E-002-2006-0-PCT-02 METHODS FOR PRODUCING AND USING PANCREATIC ENDOCRINE CELLS PCT PCT PCT/US2006/048918 Abandoned
NIAID E-233-2003-1-NZ-26 DISRUPTION OF THE PROCESSING OF THE VIRAL CAPSID-SPACER PEPTIDE 1 PROTEIN NZ National Stage 552229 Abandoned
NIEHS E-069-2007-2-US-02 The Cysteine-rich Region Of Respiratory Syncytial Virus And Methods Of Use Thereof US National Stage 11/641,625 Abandoned
NINDS E-214-2007-0-US-01 An Implanted System For Sensing, Triggering And Automatically Controlling Swallowing To Maintain Control Of Secretions US ORD 11/611,367 7734351 Abandoned PDF
NIAID E-019-1998-0-US-07 VACCINE FOR BLOCKING TRANSMISSION OF PLASMODIAM VIVAX US CON 11/611,779 7407658 Abandoned PDF
NCI E-335-2005-2-PCT-01 Optically Detectable Probes for Identification and Treatment of Tumors PCT PCT COMB PCT/US2006/047962 Abandoned
NCI E-325-2005-0-US-02 Use Of Il-15/IL-15R Complex To Expand Natural Killer And CD8 Memory T-cells US ORD 11/639,877 Abandoned
NIAID E-070-2007-0-US-01 Human Cancer Therapy Using Anthrax Lethal Toxin Activated By Tumor Associated Proteases US 60/870,050 Abandoned
NIAID E-095-2000-0-US-08 INHIBITORS OF PRE-LIGAND ASSEMBLY DOMAIN AND FUNCTION OF THE TUMOR NECROSIS FACTOR RECEPTOR FAMILY US DIV 11/637,272 9051392 Issued PDF
NCI E-195-2005-0-US-03 NANOPROBES FOR DETECTION OR MODIFICATION OF MOLECULESc US ORD 11/638,160 8344121 Abandoned PDF
NCI E-194-2005-0-FR-08 PROBE FOR NUCLEIC ACID SEQUENCING AND METHODS OF USE FR EP 06847604.3 Abandoned
NCI E-194-2005-0-DE-07 PROBE FOR NUCLEIC ACID SEQUENCING AND METHODS OF USE DE EP 06847604.3 Abandoned
NCI E-194-2005-0-EP-04 PROBE FOR NUCLEIC ACID SEQUENCING AND METHODS OF USE EP National Stage 06847604.3 Abandoned
NCI E-194-2005-0-GB-09 PROBE FOR NUCLEIC ACID SEQUENCING AND METHODS OF USE GB EP 06847604.3 Abandoned
NCI E-194-2005-0-PCT-02 PROBE FOR NUCLEIC ACID SEQUENCING AND METHODS OF USE PCT PCT PCT/US2006/047534 Expired
NCI E-195-2005-0-PCT-02 NANOPROBES FOR DETECTION OR MODIFICATION OF MOLECULES PCT PCT PCT/US2006/047456 Expired
NCI E-194-2005-0-EP-06 PROBE FOR NUCLEIC ACID SEQUENCING AND METHODS OF USE EP DIV 10176710.1 Abandoned
NCI E-194-2005-0-JP-05 PROBE FOR NUCLEIC ACID SEQUENCING AND METHODS OF USE JP National Stage 2008-545768 Abandoned
NIAID E-173-2004-1-CN-04 Methods of Using Adenoviral Vector to Induced an Immune Response CN National Stage 200580019211.9 Abandoned
NCI E-048-1997-0-US-29 METHODS OF GENE THERAPY USING NUCLEIC ACID SEQUENCES FOR ATP-BINDING CASSETTE TRANSPORTER US CON 11/636,909 8129353 Expired PDF
NCI E-150-2001-1-US-02 Use of a Promotor of T-Cell Expansion And an Inducer of CD40 Stimulation in The Treatment or Prevention of a Pathologic State US DIV 11/608,873 7368106 Abandoned PDF
NCI E-103-2006-2-PCT-01 Methods And Compositions For The Identification Of Genetic Signatures Of Heterozygous Carriers Of Mutant Suppressor Genes And Methods Of Use Thereof PCT PCT COMB PCT/US06/047222 Expired
NIA E-081-2007-0-US-01 A Cancer Chemoprevention Strategy Based On Loss Of Imprinting Of IGF2 US 60/873,830 Abandoned
NCI E-075-2004-2-US-05 Methods for the Identification and Use of Compounds Suitable for the Treatment of Drug Resistant Cancer Cells US National Stage 11/629,233 Abandoned
NCI E-321-2006-0-US-01 Regulation Of Skin Characteristics By Dickkopf 1 (DKK1) US 60/873,874 Abandoned